Home/Pipeline/Rezurock (Belumosudil)

Rezurock (Belumosudil)

Chronic Graft-vs-Host Disease

Approved (EU)ActiveN/A

Key Facts

Indication
Chronic Graft-vs-Host Disease
Phase
Approved (EU)
Status
Active
Company

About Sanofi

Sanofi is a global biopharmaceutical leader with a mission to 'chase the miracles of science' by developing innovative medicines and vaccines. The company has strategically pivoted to become an R&D-driven, AI-powered organization, focusing its deep immunoscience expertise on high-growth areas like immunology and oncology. Its strategy is centered on accelerating drug discovery, optimizing its robust pipeline, and delivering compelling growth through breakthrough therapeutics.

View full company profile